Salmonella LPS Antibody (6351): sc-58191

Salmonella LPS Antibody (6351) is a mouse monoclonal IgG1 antibody that detects Salmonella LPS of Salmonellae sp. by enzyme-linked immunosorbent assay (ELISA). Salmonella LPS, or lipopolysaccharide, plays a crucial role in the structural integrity of the bacterial cell membrane, serving as a protective barrier against environmental stresses and contributing to the pathogenicity of Salmonella species. This complex molecule consists of a lipid component known as Lipid A, which anchors the LPS to the outer membrane, an O polysaccharide that varies among different serotypes, and a core oligosaccharide that connects the two. The presence of LPS is significant not only for maintaining the structural stability of the bacteria but also for its role as an endotoxin, which can trigger severe immune responses in hosts, leading to symptoms of Salmonellosis. The ability of Salmonella LPS to elicit such responses underscores its importance in understanding the mechanisms of bacterial virulence and the development of effective therapeutic strategies. Anti-Salmonella LPS antibody (6351) is an essential tool for researchers studying the pathogenicity of Salmonella and the immune response it provokes, making it invaluable for advancing food safety and public health initiatives.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

Salmonella LPS Antibody (6351) References:

1. Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS.  |  Kirikae, T., et al. 1999. Infect Immun. 67: 1736-42. PMID: 10085012
2. Lipopolysaccharide binding protein/CD14/ TLR4-dependent recognition of salmonella LPS induces the functional activation of chicken heterophils and up-regulation of pro-inflammatory cytokine and chemokine gene expression in these cells.  |  Kogut, MH., et al. 2005. Anim Biotechnol. 16: 165-81. PMID: 16335810
3. Salmonella lipopolysaccharide (LPS) mediated neurodegeneration in hippocampal slice cultures.  |  Johansson, S., et al. 2005. Neurotox Res. 8: 207-20. PMID: 16371315
4. Vasoactive intestinal peptide (VIP) differentially affects inflammatory immune responses in human monocytes infected with viable Salmonella or stimulated with LPS.  |  Askar, B., et al. 2015. Peptides. 71: 188-95. PMID: 26206287
5. Rapid Detection of Salmonella typhimurium in Drinking Water by a White Light Reflectance Spectroscopy Immunosensor.  |  Angelopoulou, M., et al. 2021. Sensors (Basel). 21: PMID: 33920297
6. Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing.  |  Manabe, T., et al. 2021. J Neurochem. 159: 525-542. PMID: 34379806
7. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging.  |  Strittmatter, N., et al. 2021. J Am Soc Mass Spectrom. 32: 2791-2802. PMID: 34767352
8. Attenuated Salmonella Typhimurium with truncated LPS and outer membrane-displayed RGD peptide for cancer therapy.  |  Liang, K., et al. 2022. Biomed Pharmacother. 155: 113682. PMID: 36095964
9. The IRE1α-XBP1 Signaling Axis Promotes Glycolytic Reprogramming in Response to Inflammatory Stimuli.  |  English, BC., et al. 2023. mBio. 14: e0306822. PMID: 36475773
10. Specific labeling of newly synthesized lipopolysaccharide via metabolic incorporation of azido-galactose.  |  Xu, Y., et al. 2024. Biochim Biophys Acta Mol Cell Biol Lipids. 1869: 159467. PMID: 38382574